Results 181 to 190 of about 340,370 (339)

Cardiometabolic Risk in First Degree Relatives of Women With Polycystic Ovary Syndrome (PCOS)

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Polycystic ovary syndrome (PCOS) is a common multisystem disorder with reproductive, cardiometabolic and psychological implications. Genetic factors play a role in the pathogenesis of PCOS. We sought to investigate the cardiometabolic health of first degree relatives (FDR) of women with PCOS.
Su Jen Chua   +8 more
wiley   +1 more source

Safety and Effectiveness of Low‐Density Lipoprotein Cholesterol–Lowering Therapy With Evolocumab for Familial Hypercholesterolemia/Hypercholesterolemia in Japan: A Real‐World, Postmarketing, Single‐Arm Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Evolocumab is the first monoclonal antibody against proprotein convertase subtilisin/kexin type 9 approved in Japan for familial hypercholesterolemia (FH) and hypercholesterolemia; however, data on its safety and effectiveness in the real ...
Koutaro Yokote   +6 more
doaj   +1 more source

Input Visualizations to Track Health Data by Older Adults with Multiple Chronic Conditions

open access: yesComputer Graphics Forum, EarlyView.
Abstract Older adults living with multiple chronic conditions (MCC) can considerably benefit from collecting and reflecting on their health data. Many older adults collect their health data using various approaches, such as digital tools or handwritten notebooks.
Shri Harini Ramesh   +4 more
wiley   +1 more source

Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia

open access: yesArteriosclerosis, Thrombosis and Vascular Biology, 2021
M. Paquette   +8 more
semanticscholar   +1 more source

Comparative Effects of Emerging Lp(a)‐Lowering Agents and PCSK9‐Directed Therapies on Lipoprotein(a): A Network Meta‐Analysis of Randomised Clinical Trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Elevated lipoprotein(a) [Lp(a)] is a genetic ASCVD risk factor that often persists despite intensive LDL‐C lowering. We compared the efficacy and safety of emerging Lp(a)‐targeted therapies (siRNAs, antisense oligonucleotides and an oral assembly inhibitor) with PCSK9‐directed therapies.
Jihad Abu Zayed   +4 more
wiley   +1 more source

Building a precision therapeutics program at a tertiary care children's hospital

open access: yes
Pediatric Investigation, EarlyView.
Luke Hamilton   +8 more
wiley   +1 more source

Postpartum Body Weight and Cardiometabolic Biomarker Trajectories in Women With Gestational Diabetes: A Population‐Based Matched Cohort Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To compare postpartum trajectories in body weight and cardiometabolic biomarkers between women with and without GDM, and to explore the moderating effect of progression to type 2 diabetes (T2DM). Materials and Methods We used electronic primary care healthcare records and linked hospital episode records of women who gave birth between ...
Ruya Abdulsalam   +5 more
wiley   +1 more source

Family hypercholesterolemia due to LDLR gene in Vietnamese children: characteristics of phenotype and genotype

open access: yesMolecular Genetics and Metabolism Reports
Background: Familial hypercholesterolemia (FH) results in elevated LDL cholesterol, contributing to atherosclerosis and early-onset cardiovascular disease.
Mai Thi Thanh Do   +5 more
doaj   +1 more source

Familial hypercholesterolemia

open access: yesClinica Chimica Acta, 1971
Kehayoglou, K.A.   +3 more
openaire   +3 more sources

Assessment of triglyceride‐glucose composite indices associated mortality risk in diabetes‐related heart failure

open access: yesJournal of Diabetes Investigation, EarlyView.
Elevated TyG‐Age significantly increases the risk of heart failure in diabetic patients. Furthermore, combining TyG‐Age with the TRS‐HFDM score greatly enhances predictive capability and mortality risk assessment for these patients. ABSTRACT Background Patients with diabetes are at an increased risk of heart failure.
Qijie Zhao   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy